BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Business

  Humacyte Expands Strategic Global Partnership with Fresenius Medical Care

  Humacyte, Inc. announces the expansion of the strategic collaboration between Fresenius Medical Care.

  June 11, 2021

   · 

  11 min read
• Drug Development

  Scholar Rock Presents TOPAZ Phase 2 Data Showing the Transformative Potential of Apitegromab in Patients with Type 2 and 3 Spinal Muscular Atrophy (SMA) at the 2021 Virtual SMA Research & Clinical Care Meeting

  Scholar Rock today announced an oral presentation of TOPAZ Phase 2 trial results by the lead principal investigator, Thomas Crawford, M.D. of Johns Hopkins Medicine, at the Cure SMA Annual SMA Conference.

  June 11, 2021

   · 

  11 min read
• Pharvaris Announces Annual Meeting of Shareholders

  Pharvaris today announced the annual general meeting of shareholders will take place on Tuesday, June 29, 2021 at 1:00 p.m. CEST (7:00 a.m. EDT).

  June 11, 2021

   · 

  1 min read
• Aptose Presents Highlights from EHA During Corporate Update Event

  Aptose Biosciences Inc. is releasing highlights from a corporate update event being held today, Friday, June 11, 2021, at 8:00 a.m. ET.

  June 11, 2021

   · 

  8 min read
• Business

  BeyondSpring to Host First Quarter Financial Results and Corporate Update Conference Call on June 16, 2021

  BeyondSpring Inc. today announced that management will host a conference call to report its financial results for the first quarter ended March 31, 2021 and provide an update on recent corporate events on June 16, 2021 at 8:30 AM Eastern Time.

  June 11, 2021

   · 

  1 min read
• Drug Development

  Keros Therapeutics Presents Preclinical Data from ALK2 and KER-050 Hematology Programs at the European Hematology Association EHA2021 Virtual Congress

  Keros Therapeutics today presented data from the ALK2 and KER-050 hematology programs at the European Hematology Association EHA2021 Virtual Congress held from June 9 through June 17, 2021.

  June 11, 2021

   · 

  12 min read
• Drug Development

  ORYZON Presents Iadademstat ALICE 30-Month Data at EHA-2021, Confirming Positive and Robust Efficacy in Combination with Azacitidine in AML

  Oryzon Genomics, S.A.presented today new positive efficacy data from its ongoing Phase IIa ALICE trial.

  June 11, 2021

   · 

  7 min read
• US Patent Office Grants Foundational Pharmacogenomic Patent

  Genetic Technologies Limited, a diversified Genomics and AI driven preventative health business, has been granted US Patent No. 11,031,098 – ‘Computer Systems and Methods for Genomic Analysis’.

  June 11, 2021

   · 

  4 min read
• Biotech Bay

  ReCode Therapeutics Presents Preclinical Data Using SORT-LNP™ and RNA Platforms to Rescue CFTR Function at the 44th European Cystic Fibrosis Conference (ECFS)

  ReCode Therapeutics Presents Preclinical Data Using SORT-LNP ™ and RNA Platforms to Rescue CFTR Function at the 44th European Cystic Fibrosis Conference (ECFS).

  June 11, 2021

   · 

  4 min read
• Pharm Country

  SCYNEXIS to Present at the BIO Digital International Convention 2021

  SCYNEXIS, Inc. today announced that Marco Taglietti, M.D., President and Chief Executive Officer of SCYNEXIS, will present at the BIO Digital International Convention to be held virtually from June 10 – 11 and 14 – 18, 2021.

  June 11, 2021

   · 

  2 min read